S
Sergiu Popa
Publications - 1
Citations - 355
Sergiu Popa is an academic researcher. The author has contributed to research in topics: FEV1/FVC ratio. The author has an hindex of 1, co-authored 1 publications receiving 311 citations.
Papers
More filters
Journal ArticleDOI
Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group
Suzana Jordan,Jörg H W Distler,Britta Maurer,Dörte Huscher,Jacob M van Laar,Yannick Allanore,Oliver Distler,Tore K Kvien,Paolo Airò,Juan José Alegre Sancho,Lidia Ananjeva,Codrina Michaela Ancuta,Martin Aringer,Alexandra Balbir-Gurman,Francesco Paolo Cantatore,Paola Caramaschi,Emmanuel Chatelus,Veronica Codullo,Dominique Farge-Bancel,Rosario Foti,Armando Gabrielli,Jörg Henes,I. Herrgott,Florenzo Iannone,Francesca Ingegnoli,Esthela Loyo,Marco Matucci-Cerinic,Walid Ahmed Abdel Atty Mohamed,Ulf Müller-Ladner,Øyvind Palm,Sergiu Popa,Gabriela Riemekasten,Simona Rednic,Edoardo Rosato,M. Saracco,Agneta Scheja,Vanessa Smith,Carina Mihai,Gabriela Szucs,Matija Tomšič,Gabriele Valentini,Ulrich A. Walker,Rene Westhovens,Sule Yavuz,Thierry Zenone +44 more
TL;DR: The comparison of RTX treated versus untreated matched-control SSc patients from the EUSTAR cohort demonstrated improvement of skin fibrosis and prevention of worsening lung fibrosis, supporting the therapeutic concept of B cell inhibition in SSc.